본문 바로가기

Rifampin으로 인한 간손상에 UDCA와 인진호탕 병용투여 증례 보고

A Case Report of UDCA and Injinho-tang Co-administration for Liver Damage Caused by Rifampin

문서 유형
연구출판물 · 학술지 논문
등재
KCI
저널 순위
KCI Q3
저널
대한한방내과학회지44(5) · pp.1011 · 2023
피인용
KCI 0
ISSN
1226-9174

저자

  1. 이세연제1저자부산대학교 한방병원 한방내과
  2. 윤한성부산대학교 한의학전문대학원 한의학과
  3. 구기범부산대학교 한방병원 한방내과
  4. 김마리아부산대학교한방병원 한방내과
  5. 남이랑부산대학교 한방병원 한방내과
  6. 김민화부산대학교 한방병원 한방내과
  7. 한창우교신저자부산대학교한방병원 한방내과

초록

We have experienced a case in which herbal medicine was administered to treat drug-induced liver damage and would like to introduce it. A 49-year-old man exhibited a positive result in the interferon-gamma release assay. He had never suffered from tuberculosis in the past, and the route and time of infection could not be confirmed. He had no respiratory or systemic symptoms suggestive of active tuberculosis, and a chest X-ray examination showed no active lung lesions, so he was diagnosed with latent tuberculosis infection. He was confirmed to be within the normal range in the liver function test, renal function test, and complete blood cell count test, and started taking rifampin (600 mg qd). In the screening test performed on the 19th day of taking the drug, other test items were normal, but alanine aminotransferase (ALT) increased to 50 U/L (reference value: 4-40 U/L). In a test performed on the 29th day of taking the drug, ALT was clearly elevated to 102 U/L. Ursodeoxycholic acid and Injinho-tang were taken together with rifampin, and the patient’s progress was observed. In a test performed 14 days later, ALT decreased to 26 U/L, within the normal range. It is presumed that Injinho-tang may have partially contributed to alleviating liver damage in this case.

키워드

Injinho-tangrifampinlatent tuberculosis infectiondrug-induced liver injury

식별자

KCI
ART003015635